Becton dickenson biosciences flow cytometer maintenance agreements.

Ended Awarded Last action

Contract number
HHSF223201310332G
Awardee
Awarding agency
Obligated
$73,321

Award facts

Contract value 100% obligated
$73,320.73 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20903, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 1 · "other function" - becton dickenson biosciences flow cytometer maintenance agreements. $0
Original award $73,321

About this award

This delivery order awards Becton, Dickinson and Company, through its BD Biosciences division, a $73,320.73 firm fixed-price contract for maintenance agreements on Becton Dickinson Biosciences flow cytometer equipment at the Food and Drug Administration's facility in Silver Spring, Maryland. The award, issued on June 12, 2013, with an ultimate completion date of July 11, 2014, supports the FDA's laboratory and diagnostic operations through preventive maintenance and technical support services for flow cytometry instrumentation. This contract was awarded without a set-aside designation, reflecting BD Biosciences' established position as a qualified large business contractor in the federal marketplace. No subcontractors are identified in this award documentation.

The Food and Drug Administration relies on sophisticated flow cytometry systems for biomedical research and diagnostic analysis essential to regulatory decision-making and product evaluation. BD Biosciences represents a primary federal supplier of flow cytometry platforms and comprehensive maintenance services, with extensive contracting relationships across multiple federal health and research agencies including the Department of Veterans Affairs, National Institutes of Health, Centers for Disease Control and Prevention, and Defense Health Agency. This maintenance agreement ensures uninterrupted operational capability of the FDA's flow cytometry assets through priority technical support and service visits, supporting the agency's mission to protect public health through rigorous scientific analysis and regulatory oversight.

Quick answers

Who was awarded contract HHSF223201310332G?

HHSF223201310332G was awarded to Becton, Dickinson And Company by Food and Drug Administration (Department of Health and Human Services) on June 12, 2013.

How much is contract HHSF223201310332G worth?

The government has obligated $73,321 on HHSF223201310332G.

Is contract HHSF223201310332G an order under another contract?

Yes. HHSF223201310332G is a delivery order under GS24F2044D, a federal supply schedule.

Was contract HHSF223201310332G competed?

The extent of competition for HHSF223201310332G was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award